Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in Adolescents

NCT01689324 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Pertussis
Tetanus
Diphtheria

Interventions

BIOLOGICAL: (ADACEL®): Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis

Sponsor

Sanofi Pasteur, a Sanofi Company